2017
DOI: 10.1038/ni.3857
|View full text |Cite|
|
Sign up to set email alerts
|

A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes

Abstract: The hygiene hypothesis postulates that the recent increase in allergic diseases such as asthma and hay fever observed in Western countries is linked to reduced exposure to childhood infections. Here we investigated how infection with a gammaherpesvirus affected the subsequent development of allergic asthma. We found that murid herpesvirus 4 (MuHV-4) inhibited the development of house dust mite (HDM)-induced experimental asthma by modulating lung innate immune cells. Specifically, infection with MuHV-4 caused t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

11
214
0
4

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 183 publications
(229 citation statements)
references
References 52 publications
11
214
0
4
Order By: Relevance
“…Moreover, it will be interesting to see whether any of the currently licenced or future vaccines has the potential to induce heterologous protection from viral infection as well as asthma. Recently, gammaherpesvirus infection was shown to induce regulatory monocytes, which prevented experimental asthma in mice [149]. erefore, heterologous innate immune stimulation with tolerogenic or T1 promoting adjuvants [14] might be utilised to induce allergen tolerance (Fig.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Moreover, it will be interesting to see whether any of the currently licenced or future vaccines has the potential to induce heterologous protection from viral infection as well as asthma. Recently, gammaherpesvirus infection was shown to induce regulatory monocytes, which prevented experimental asthma in mice [149]. erefore, heterologous innate immune stimulation with tolerogenic or T1 promoting adjuvants [14] might be utilised to induce allergen tolerance (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Vaccination with self-amplifying mRNA (SAM®) (GlaxoSmithKline, London, UK) in lipid nanoparticles, encoding for conserved internal IV A proteins (nucleoprotein [NP] and/or matrix protein 1 [M1]), induced proliferation of NP-and M1-speci c CD4 + 1 cells as well as NP [147][148][149][150][151][152][153][154][155] -speci c CD8 + T cells in mice. All vaccinated mice survived hetero-subtypic IV A challenge [64].…”
Section: In Uenza Virus (Iv)mentioning
confidence: 99%
See 3 more Smart Citations